8-K Announcements
6Material company update
Apr 30, 2026·SEC
Material company update
Mar 27, 2026·SEC
Material company update
Feb 12, 2026·SEC
Pro-Dex, Inc.(PDEX)Earnings, Financials & Key Ratios
PDEX•NASDAQ
$58.87
22.0× P/E·Price updated Jul 7, 2026
AboutPro-Dex, Inc. designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company was founded in 1978 and is headquartered in Irvine, California.Show more
- Revenue$67M+23.7%
- EBITDA$12M+43.1%
- Net Income$9M+322.1%
- EPS (Diluted)2.67+345.0%
- Gross Margin29.3%+8.4%
- EBITDA Margin17.91%+15.7%
- Operating Margin16.05%+20.5%
- Net Margin13.48%+241.3%
- ROE26.6%+290.6%
PDEX Price & Volume
Pro-Dex, Inc. (PDEX) stock price & volume — 10-year historical chart
Loading chart...
Revenue Growth Masks Volatile Cash Flow Risks
Investment Thesis • Updated 2026Q3
VerdictNeutral
Growth:Expanding
Profitability:Moderate
Financial:Vulnerable
Cash Flow:Mixed
Primary Risk:Extreme customer concentration risk
Key Thesis Takeaways
- Pro-Dex demonstrates consistent top-line expansion, evidenced by a 14.6% year-over-year revenue increase to $19.9 million in 2026Q3, driven by its integration into specialized surgical OEM platforms.
- However, the company's reliance on a concentrated customer base and its history of erratic cash conversion, including a negative 27.9% FCF margin in 2025Q2, present significant operational risks.
- Investors should remain cautious as the firm's capital allocation, specifically the $2.2 million share repurchase in 2026Q2, appears aggressive given the historical volatility in working capital and liquidity.
Verdict Logic
while the company shows 14.6% revenue growth, the high valuation multiple of 17.88x EV/EBITDA combined with extreme working capital volatility warrants a wait-and-see approach.
PDEX Growth Metrics
Pro-Dex, Inc. (PDEX) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years17.41%
5 Years13.84%
3 Years16.57%
TTM16.39%
Profit CAGR
10 Years-
5 Years7.99%
3 Years25.23%
TTM28.11%
EPS CAGR
10 Years-
5 Years12.22%
3 Years30.19%
TTM29.29%
Return on Capital
10 Years18.75%
5 Years17.29%
3 Years18.93%
Last Year24.82%
PDEX Recent Earnings
Pro-Dex, Inc. (PDEX) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 9/12 qtrs (75%)●Beat Revenue 10/12 qtrs (83%)
Q2 2026Latest
Apr 30, 2026Metric
Actual
Est
EPS
$1.20+93.5%
$0.62
Rev
$20M+11.4%
$18M
Q1 2026
Jan 29, 2026Metric
Actual
Est
EPS
$0.66+11.9%
$0.59
Rev
$19M+7.9%
$17M
Q4 2025
Oct 30, 2025Metric
Actual
Est
EPS
$0.62+24.0%
$0.50
Rev
$19M+21.1%
$15M
Q4 2025
Sep 4, 2025Metric
Actual
Est
EPS
$0.36-23.4%
$0.47
Rev
$17M+14.3%
$15M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 30, 2026 | $1.20vs $0.62+93.5% | $20Mvs $18M+11.4% |
| Q1 2026 | Jan 29, 2026 | $0.66vs $0.59+11.9% | $19Mvs $17M+7.9% |
| Q4 2025 | Oct 30, 2025 | $0.62vs $0.50+24.0% | $19Mvs $15M+21.1% |
| Q4 2025 | Sep 4, 2025 | $0.36vs $0.47-23.4% | $17Mvs $15M+14.3% |
Based on last 12 quarters of dataView full earnings history →
Peers Comparison
Key metrics vs top competitors for Pro-Dex, Inc. (PDEX)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $58.87 | $188.74M | 22.05 | 23.68% | 13.48% | 26.6% | — | |
| $13.56 | $37.89M | -149.34 | -7.62% | 0.85% | 3.03% | — | |
| $0.75 | $7.49M | -0.85 | 13.03% | -55.45% | -79.65% | — | |
| $32.80 | $1.66B | -136.67 | 14.88% | -0.83% | -0.95% | — | |
| $72.14 | $4.3B | 33.87 | 11.66% | 9.03% | 8.95% | — | |
| $17.72 | $2.02B | -14.52 | 8.28% | -25.66% | -50.82% | — |
Compare PDEX vs Peers
Pro-Dex, Inc. (PDEX) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
PDEX SEC Filings & Documents
Pro-Dex, Inc. (PDEX) SEC filings — annual & quarterly reports (10-K, 10-Q)
Get notified when PDEX posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
PDEX Frequently Asked Questions
Pro-Dex, Inc. (PDEX) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is Pro-Dex, Inc.'s revenue?
Pro-Dex, Inc. (PDEX) reported $74.6M in revenue for fiscal year 2025. This represents a 259% increase from $20.8M in 1996.
How fast is Pro-Dex, Inc. growing?
Pro-Dex, Inc. (PDEX) grew revenue by 23.7% over the past year. This is strong growth.
Is PDEX profitable?
Yes, Pro-Dex, Inc. (PDEX) is profitable, generating $12.0M in net income for fiscal year 2025 (13.5% net margin).
Dividend & Returns
What is PDEX's return on equity?
Pro-Dex, Inc. (PDEX) has a return on equity (ROE) of 26.6%. This is excellent, indicating efficient use of shareholder capital.
What is Pro-Dex, Inc.'s free cash flow?
Pro-Dex, Inc. (PDEX) generated $7.1M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.